Uropharma Limited

Active08083943 Private limited company

Incorporated: 25 May 2012 (14 years)
Industry: Manufacture of medical and dental instruments and supplies (32500)
Directors: Mark Edward Donaldson
Martin William O'Donoghue
Andrew Neil Sharkey
all 5 directors
Owned by: Scott Glickman
Accounts type: Total exemption full
Region: East of England
Address: 5 Enterprise House
Norwich Research Park Colney Lane
Colney
Norwich
NR4 7UG

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 21 June 2027
Last conf. stmt: 7 June 2026

Officers 6 active

Officer details are public data from the Companies House register.

Donaldson, Mark Edward

Director · Appointed 1 February 2024

Also at Mint Consult Limited, Mint Consultancy Limited, Cascade Limited

British

Born March 1980 (46)

O'Donoghue, Martin William

Director · Appointed 1 February 2024

Also at Odc Corporate Services Ltd

Irish

Born August 1977 (49)

Sharkey, Andrew Neil

Director · Appointed 1 February 2024

British

Born May 1958 (68)

Glickman, Scott

Director · Appointed 2 August 2012

Also at Uropharma, Inc., Jotillou Enterprises Limited, Viscus Medical Ltd · more companies

American

Born November 1949

Shapland, Howard Terence Pemberthy

Secretary · Appointed 25 May 2012

British

Shapland, Howard Terence

Director · Appointed 25 May 2012

Also at Uropharma, Inc., Secondbridge Holdings Limited, Bioventure Limited · more companies

British

Born July 1943 (83)

Officer history (3 former)

1 February 2024

Appointed Donaldson, Mark Edward as Director

1 February 2024

Appointed O'Donoghue, Martin William as Director

1 February 2024

Appointed Sharkey, Andrew Neil as Director

20 November 2018

Resigned Fogel, Steven Anthony as Director

8 August 2017

Resigned Wilkinson, Graeme Francis, Dr as Director

1 April 2015

Appointed Wilkinson, Graeme Francis, Dr as Director

2 August 2012

Appointed Glickman, Scott as Director

2 August 2012

Appointed Fogel, Steven Anthony as Director

25 May 2012

Appointed Shapland, Howard Terence Pemberthy as Secretary

25 May 2012

Appointed Shapland, Howard Terence as Director

25 May 2012

Appointed Kahan, Barbara as Director

25 May 2012

Resigned Kahan, Barbara as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Scott Glickman

Individual · Notified 4 October 2017

Owns 25–50% of shares

American

Born November 1949

Former controllers (3)

4 October 2017

Ceased Uropharma, Inc. — Owns 75–100% of shares

4 October 2017

Ceased Scott Glickman — Owns 25–50% of shares

4 October 2017

Ceased Howard Terence Shapland — Owns 25–50% of shares

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To
21 July 2026	Confirmation statement with no updates	7 June 2026
18 March 2026	Registered office address changed
17 October 2025	Total exemption full accounts	31 December 2024
18 July 2025	Confirmation statement with updates	7 June 2025
17 July 2025	Statement of capital following an allotment of shares